Depreciation of DMK PHARMACEUTICALS Corp from 30 Jun 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
DMK PHARMACEUTICALS Corp quarterly and annual Depreciation in USD history and change rate from 30 Jun 2010 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Depreciation for the quarter ending 30 Sep 2023 was $67,000, a 83% decline year-over-year.
  • DMK PHARMACEUTICALS Corp Depreciation for the twelve months ending 30 Sep 2023 was $636,000, a 57% decline year-over-year.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2022 was $1,484,000, a 3.3% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2021 was $1,436,000, a 9.8% increase from 2020.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2020 was $1,308,000, a 119% increase from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

DMK PHARMACEUTICALS Corp Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $636,000 $67,000 -$332,000 -83% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $968,000 $87,000 -$281,000 -76% 01 Apr 2023 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 $1,249,000 $109,000 -$235,000 -68% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,484,000 $373,000 +$9,000 +2.5% 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
Q3 2022 $1,475,000 $399,000 +$24,000 +6.4% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $1,451,000 $368,000 -$1,000 -0.27% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 $1,452,000 $344,000 +$16,000 +4.9% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $1,436,000 $364,000 +$178,000 +96% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $1,258,000 $375,000 +$33,000 +9.6% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,225,000 $369,000 -$27,000 -6.8% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $1,252,000 $328,000 -$56,000 -15% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $1,308,000 $186,000 +$38,000 +26% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $1,270,000 $342,000 +$193,000 +130% 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021 2021 Q3
Q2 2020 $1,077,000 $396,000 +$251,000 +173% 01 Apr 2020 30 Jun 2020 10-Q 22 Nov 2021 2021 Q2
Q1 2020 $826,000 $384,000 +$228,000 +146% 01 Jan 2020 31 Mar 2020 10-Q 22 Nov 2021 2021 Q1
Q4 2019 $598,000 $148,000 -$12,000 -7.5% 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 $610,000 $149,000 -$8,000 -5.1% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $618,000 $145,000 -$9,000 -5.8% 01 Apr 2019 30 Jun 2019 10-Q 17 Aug 2020 2020 Q2
Q1 2019 $627,000 $156,000 +$4,000 +2.6% 01 Jan 2019 31 Mar 2019 10-Q 18 May 2020 2020 Q1
Q4 2018 $623,000 $160,000 +$34,000 +27% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $589,000 $157,000 +$18,000 +13% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $571,000 $154,000 -$5,000 -3.1% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $576,000 $152,000 -$12,000 -7.3% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $588,000 $126,000 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 $139,000 -$28,719 -17% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $159,000 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $164,000 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q3 2016 $167,719 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2010 $5,783 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q1

DMK PHARMACEUTICALS Corp Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,484,000 +$48,000 +3.3% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $1,436,000 +$128,000 +9.8% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,308,000 +$710,000 +119% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $598,000 -$25,000 -4% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
2018 $623,000 +$35,000 +6% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $588,000 +$103,000 +21% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 $485,000 +$465,580 +2397% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
2015 $19,420 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2013 $4,855 01 Apr 2013 31 Mar 2014 10-KT 26 Mar 2015 2014 FY
2010 $14,648 01 Apr 2010 31 Mar 2011 10-K 29 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.